Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
9 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06402188 | ColoSeal™ ICD System Safety and Feasibility Studies(PROTECT I) | active not recruiting | N/A | 90 | Averto Medical, Inc.INDUSTRY | 3 | Sep 10, 2026 | clinicaltrials |
| NCT07303660 | A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients | recruiting | Phase 1 | 66 | Lomond Therapeutics Holdings, Inc.INDUSTRY | 2 | Aug 31, 2026 | clinicaltrials |
| NCT07524140 | A First-in-Human Study of ZE94-0605 in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 60 | Eilean TherapeuticsINDUSTRY | 2 | Jul 29, 2026 | clinicaltrials |
| NCT07435324 | A Comparative Study of Efficacy and Safety of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma | completed | Phase 3 | 161 | R-PharmINDUSTRY | 2 | Jul 14, 2026 | clinicaltrials |
| NCT06540807 | SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study | completed | N/A | 24 | SafeHeal IncINDUSTRY | 1 | May 20, 2026 | clinicaltrials |
| NCT07325682 | Diagnostic Evaluation of Viral Persistence in Cervical Cancer(PETCVOCC) | enrolling by invitation | N/A | 30 | Oncology Center,Ministry Of Heath,UzbekistanOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT01953770 | Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008(ALL-MB 2008) | unknown | N/A | 3,000 | Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyOTHER | 3 | Feb 5, 2020 | clinicaltrials |
| NCT03390387 | Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2015 (ALL-MB 2015)(ALL-MB 2015) | unknown | N/A | 4,000 | Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyOTHER | 5 | Feb 5, 2020 | clinicaltrials |
| NCT03311542 | Expanded Access for Pembrolizumab (MK-3475) | no longer available | — | — | Center Trials & TreatmentOTHER | 4 | Jan 10, 2018 | clinicaltrials |
Data updated 19 days agoSource updated unknownsource: clinicaltrials